Page 48 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 48

20    Part I  Molecular and Cellular Basis of Hematology


        4  (H3K4me1/2)  and  acetylation  of  H3  lysine  27  (H3K27ac)  are   CHROMATIN REMODELERS
        marks  of  active enhancers, and  the  degree of  H3K27ac  is broadly
        correlated with enhancer activation. H3K27ac is the enhancer mark   Chromatin  remodeling  alters  the  position,  occupancy,  or  histone
        most commonly used to define superenhancers.          composition of a nucleosome within chromatin. Adenosine triphos-
           Several  histone  modifications  are  particularly  associated  with   phate (ATP)-dependent changes in nucleosome position and occu-
        repressed  genes:  trimethylation  of  H3  lysine  27  (H3K27me3),  di-   pancy  are  mediated  by  the  multisubunit  chromatin  remodeling
        and trimethylation of H3 lysine 9 (H3K9me2/3), and trimethylation   complexes, which fall into four families: switch/sucrose nonferment-
        of  H4  lysine  20  (H4K20me3).  H3K27me3  is  deposited  at  both   able  (SWI/SNF),  imitation  SWI  (ISWI),  chromodomain  helicase
        promoters  and  enhancers  by  the  polycomb  repressive  complex  2   DNA  binding  (CHD),  and  INO80.  ATP-independent  changes  in
        (PRC2) and mediates recruitment of PRC1, resulting in chromatin   nucleosome position and occupancy can occur in response to tran-
        condensation  and  transcriptional  repression.  H3K9me2/3  and   scription factor binding or through the action of histone chaperones
        H4K20me3  are  both  highly  associated  with  heterochromatin.   that can deposit, remove, or exchange histones. Each of these activi-
        H3K9me2/3 serves as a binding site for heterochromatin protein 1   ties alters the accessibility of DNA to transcription factors and other
        (HP1). HP1 recruits additional histone-modifying enzymes, includ-  DNA-binding proteins.
        ing the lysine methyltransferases KMT5B and KMT5C that produce   Complexes in the SWI/SNF family include the Brg1/Brm-associ-
        H4K20me3.                                             ated  factor  (BAF)  complex,  polybromo-associated  BAF  (PBAF)
           Stem cells harbor promoters marked by both activating H3K4me3   complex,  and  Williams  syndrome  transcription  factor  including
        and  repressive  H3K27me3.  Upon  cellular  differentiation,  these   nucleosome assembly complex (WINAC). They contribute to tran-
        “bivalent” or “poised” promoters are rapidly converted to either an   scriptional regulation and DNA repair. In addition to nucleosome
        activated or a repressed state.                       sliding,  SWI/SNF  complexes  have  been  implicated  in  chromatin
           The  Aurora  B  kinase  phosphorylates  histone  H3  at  serine  10   looping as well as in eviction of H2A/H2B dimers from the nucleo-
        (phospho-H3S10),  triggering  chromosome  condensation  during   some.  Members  of  the  INO80  family  of  complexes  participate  in
        mitosis.  Phosphorylation  of  H2B  at  serine  14  (phospho-H2BS14)   transcription and DNA repair, but they can also catalyze the exchange
        mediates chromatin condensation during apoptosis.     of histones from the nucleosome structure. For example, SRCAP can
                                                              exchange  the  H2A/H2B  histone  dimer  for  a  variant  H2A.Z/H2B
                                                              dimer, which is associated with actively transcribed promoters. The
        TRANSCRIPTION FACTORS                                 CHD  nucleosome  remodeling  family  is  the  largest,  and  its  best-
                                                              characterized  member  is  the  nucleosome  remodeling  deacetylase
        A transcription factor is a protein that binds to specific DNA sequences   (NURD) complex. A subset of NURD complexes incorporates the
        and  contributes  to  modulation  of  gene  expression.  Transcription   MBD2  subunit,  which  preferentially  binds  methylated  DNA,  and
        factors are the key determinants of the epigenetic state of the cell.   promotes the repression of genes through its remodeling and HDAC
        They are modular in structure and contain the following domains:  activities. Many alternative NURD complexes incorporate different
                                                              DNA-binding proteins and can contribute to transcriptional activa-
        •  A DNA-binding domain (DBD), having high affinity for specific   tion.  ISWI  family  chromatin  remodeling  complexes  catalyze  the
           sequences of DNA                                   sliding of nucleosomes in short increments and participate in nucleo-
        •  A  trans-activating  domain  (TAD)  or  trans-repressive  domain   some spacing after DNA replication, RNA polymerase elongation,
           (TRD),  mediating  protein–protein  interactions  with  transcrip-  transcriptional regulation, and DNA damage repair.
           tional coregulators                                   Remarkably,  cancer  genome  sequencing  studies  have  identified
        •  An optional signal-sensing domain (SSD) (e.g., a ligand binding   frequent inactivating mutations in chromatin remodelers in a variety
           domain),  which  can  modulate  DNA-binding  and/or  protein-  of human cancers. The SWI/SNF complex has particularly emerged
           binding activity in response to cellular cues      as a powerful tumor suppressor whose disruption occurs in nearly
                                                              20% of primary human tumors.
        DNA sequences having high affinity for transcription factor binding
        are often referred to as response elements. Transcription factor binding
        to accessible promoters and enhancers recruits additional proteins,   EXPERIMENTAL APPROACHES IN EPIGENETICS
        such  as  coactivators/corepressors,  chromatin  remodelers,  histone-
        modifying  enzymes,  and  RNA  polymerases,  to  modulate  gene   As  dramatically  as  high-throughput  sequencing  has  impacted  the
        expression.                                           ability  to  understand  the  genome,  its  facilitation  of  epigenomic
           Although sequence-specific DNA binding is a defining feature of   research has been equally profound. A wide variety of experimental
        transcription factors, chromatin accessibility is a key determinant of   approaches are in use and in development for epigenomic research,
        transcription factor binding. Most transcription factors preferentially   but  most  are  predicated  on  detecting  (1)  DNA  methylation,  (2)
        bind  nucleosome-free  DNA.  In  many  cases,  a  transcription  factor   protein–DNA interactions, (3) chromatin accessibility, and (4) three-
        needs to compete for DNA binding with other transcription factors,   dimensional chromatin structure/looping (Fig. 2.3).
        histones,  and  nonhistone  chromatin  proteins.  The  competitive   A key feature of all of these techniques is the ability to isolate a
        balance  between  nucleosome  and  transcription  factor  binding  is   subset of DNA sequences from the larger genome on the basis of a
        critically affected by chromatin remodeling complexes (see later). In   specific chromatin feature. This has several practical implications for
        practice, only a small fraction of potential response elements is actu-  experiments. First, many techniques rely on cross-linking agents such
        ally bound, and many experimentally detected transcription factor   as formaldehyde to covalently link proteins to each other and to the
        binding sites (TFBS) lack canonical response elements. The genome-  DNA they bind. Cross-linking rapidly kills cells and “freezes” chro-
        wide  pattern  of  transcription  factor  binding  can  be  determined   matin. Second, all of these experimental techniques involve fragment-
        experimentally  using  chromatin  immunoprecipitation  (ChIP)  and   ing  chromosomes  into  much  smaller  pieces,  either  by  physical
        next-generation sequencing (ChIP-Seq; see later) and is known as the   disruption  (sonication)  or  by  endonuclease  treatment.  Third,  the
        transcription factor cistrome.                        chromatin subset of interest is extracted and enriched by immuno-
           Different cell types typically express both common and distinct   precipitation, isolation of chromatin fragments of specific sizes, and/
        transcription factors. Moreover, the cistrome of a transcription factor   or  sequence-specific  amplification  via  polymerase  chain  reaction
        differs among cell types, reflecting differences in chromatin accessibil-  (PCR).  Finally,  DNA  is  isolated  from  this  chromatin  subset  and
        ity  and  helping  to  define  active  promoters  and  enhancers.  Master   subjected to next-generation sequencing.
        transcription factors are a special subset of lineage-defining transcrip-  A common technique for determining the genome-wide methy-
        tion  factors  having  expression  restricted  to  specific  cell  types  and   lome is bisulfite-sequencing. Treatment of DNA with bisulfite con-
        demonstrating very high binding at superenhancers.    verts cytosine residues to uracil but leaves 5-methylcytosine (5mC)
   43   44   45   46   47   48   49   50   51   52   53